论文部分内容阅读
目的:探索止消通脉宁对糖尿病微血管合并症患者心功能的价值。方法:以我院接治的60例糖尿病微血管合并症患者作为本次研究对象,将其随机分为观察组与对照组,对比治疗前后两组患者心功能、眼底及24h尿蛋白定量等指标,以此评估止消通脉宁的临床应用价值。结果:经统计发现,观察组共计5例临床缓解、11例显效、10例有效,总有效率达到86.7%,明显优于对照组73.3%的总有效率和26.7%的无效率,两组差异具有统计学意义(P<0.05),此外,观察组治疗后24h尿白蛋白定量、超声心动以及心功能等各项指标均明显优于治疗前(P<0.05),且差异具有统计学意义。结论:止消通脉宁能够有效改善糖尿病微血管合并症患者的临床症状,提高患者心脏功能,改善其生活质量,在实践中值得推广应用。
Objective: To explore the value of Zhixiaotongmaining on cardiac function in patients with diabetic microvascular complications. Methods: Sixty patients with diabetic microvascular complications who were treated in our hospital were selected as the study subjects. They were randomly divided into observation group and control group. Before and after treatment, cardiac function, fundus and 24 h urinary protein were compared. In order to evaluate the clinical application of Zhixintongmaining. Results: According to the statistics, 5 cases of clinical remission, 11 cases of effective, 10 cases of effective, the total effective rate was 86.7%, significantly better than the control group 73.3% of the total effective rate and 26.7% of the inefficiency, the difference between the two groups (P <0.05). In addition, the urinary albumin quantitation, echocardiography and cardiac function in the observation group were significantly better than those before treatment (P <0.05), and the difference was statistically significant. Conclusion: Zhixiaotongmaining can effectively improve the clinical symptoms of patients with diabetic microvascular complications, improve cardiac function and improve their quality of life, which is worth promoting in practice.